Learning Objective
![The figure demonstrates how a neurotransmitter and drugs bind to receptors to cause different effects. When a neurotransmitter fits into the receptor, binding is successful. An agonist is similar to a neurotransmitter in that it can bind to a receptor successfully. An antagonist does not bind successfully because it cannot fit into the receptor, but it does block the receptor from being bound by another drug or neurotransmitter. The receptor is like a look with a specific shape, in which only keys with certain shapes can fit and bind successfully.](asset/shell/images/preloader.gif)
Contrast the effects of agonist drugs and antagonist drugs on neural communication at a synapse.
Contrast the effects of agonist drugs and antagonist drugs on neural communication at a synapse.
Review
1. Agonists and antagonists are chemicals that influence synaptic transmission. Normally, a message is passed from one neuron to the next at a synapse. Neurotransmitters released from the sending neuron drift across the synaptic gap and bind to receptors on the receiving neuron, triggering a neural impulse in the receiving neuron.
Review
2. An agonist drug works with the neurotransmitter, enhancing its effect and making it more likely that the message will be passed. An antagonist drug works against the neurotransmitter, reducing its effect and making it less likely to trigger a neural impulse in the receiving neuron.
Review
3. Most antagonist drugs directly block the neurotransmitter. The shape of the antagonist molecule is just similar enough to the neurotransmitter that it can fit partway into the receptors, but not similar enough to stimulate the receptors. Because this prevents the actual neurotransmitter from binding to the receptors, it produces the same effect as decreasing the number of neurotransmitters in the synaptic gap.
Review
4. Some agonist drugs mimic the neurotransmitter. The shape of the agonist molecule is similar enough to the neurotransmitter that it can bind directly to the receptors and stimulate them, producing the same effect as releasing additional neurotransmitters into the synaptic gap.
Review
5. Other agonist drugs block the reuptake of the neurotransmitter into the axon terminal. This enhances the effect of the neurotransmitter by prolonging the time that neurotransmitters remain in the synaptic gap.
Review
6. Finally, some agonist drugs slow down the removal of the neurotransmitter from the synaptic gap by interfering with the enzymes that break the neurotransmitter molecules into smaller pieces that can be reabsorbed into the axon terminal. This increases the effect of the neurotransmitter by lengthening the time that the neurotransmitters remain in the synaptic gap.
Practice: Agonist and Antagonist Effects
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window.
Quiz 1
True | False | |
---|---|---|
Reuptake is the process of removing neurotransmitter molecules from the synaptic gap by absorbing them back into the axon terminal so that they can be released when the next neural impulse arrives. |
||
Left undisturbed, neurotransmitter molecules in the synaptic gap will continue to bind, unbind, and rebind to receptor sites, continuously sending their message. |
||
One way of stopping the activity of neurotransmitters is to have them bind permanently to the receptors on the postsynaptic membrane. |
Quiz 2
Agonist | Antagonist | |
---|---|---|
Drug Z45 targets the neurotransmitter norepinephrine. It appears to interfere with the enzyme that breaks down the norepinephrine molecules. |
||
Drug H22 targets the neurotransmitter dopamine. It appears to block the dopamine receptors on the postsynaptic membrane. |
||
Drug T06 targets the neurotransmitter serotonin. It appears to block the reuptake of the serotonin molecules into the presynaptic membrane. |
||
Drug M87 targets the neurotransmitter GABA. It appears to bind to the GABA receptors on the postsynaptic neuron and to fully activate those receptors. |